1-3 of 3
Megan O’Grady
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Study Design and Baseline Characteristics of the CARDINAL Trial: A Phase 3 Study of Bardoxolone Methyl in Patients with Alport Syndrome

Subject Area:
Nephrology
Glenn M. Chertow, Gerald B. Appel, Sharon Andreoli, Sripal Bangalore, Geoffrey A. Block, Arlene B. Chapman, Melanie P. Chin, Keisha L. Gibson, Angie Goldsberry, Kazumoto Iijima, Lesley A. Inker, Bertrand Knebelmann, Laura H. Mariani, Colin J. Meyer, Kandai Nozu, Megan O’Grady, Arnold L. Silva, Peter Stenvinkel, Roser Torra, Bradley A. Warady, Pablo E. Pergola
Journal: American Journal of Nephrology
Am J Nephrol (2021) 52 (3): 180–189.
https://doi.org/10.1159/000513777
Published Online: 31 March 2021
View article titled, Study Design and Baseline Characteristics of the CARDINAL Trial: A Phase 3 Study of Bardoxolone Methyl in Patients with Alport Syndrome
Open the PDF for Study Design and Baseline Characteristics of the CARDINAL Trial: A Phase 3 Study of Bardoxolone Methyl in Patients with Alport Syndrome in another window
Journal Articles

Bardoxolone Methyl Improves Kidney Function in Patients with Chronic Kidney Disease Stage 4 and Type 2 Diabetes: Post-Hoc Analyses from Bardoxolone Methyl Evaluation in Patients with Chronic Kidney Disease and Type 2 Diabetes Study

Subject Area:
Nephrology
Melanie P. Chin, George L. Bakris, Geoffrey A. Block, Glenn M. Chertow, Angie Goldsberry, Lesley A. Inker, Hiddo J.L. Heerspink, Megan O’Grady, Pablo E. Pergola, Christoph Wanner, David G. Warnock, Colin J. Meyer
Journal: American Journal of Nephrology
Am J Nephrol (2018) 47 (1): 40–47.
https://doi.org/10.1159/000486398
Published Online: 18 January 2018
View article titled, Bardoxolone Methyl Improves Kidney Function in Patients with Chronic Kidney Disease Stage 4 and Type 2 Diabetes: Post-Hoc Analyses from Bardoxolone Methyl Evaluation in Patients with Chronic Kidney Disease and Type 2 Diabetes Study
Open the PDF for Bardoxolone Methyl Improves Kidney Function in Patients with Chronic Kidney Disease Stage 4 and Type 2 Diabetes: Post-Hoc Analyses from Bardoxolone Methyl Evaluation in Patients with Chronic Kidney Disease and Type 2 Diabetes Study in another window
Journal Articles

Mechanisms Contributing to Adverse Cardiovascular Events in Patients with Type 2 Diabetes Mellitus and Stage 4 Chronic Kidney Disease Treated with Bardoxolone Methyl

Subject Area:
Topic Article Package: Diabetes , Nephrology
Melanie P. Chin, Scott A. Reisman, George L. Bakris, Megan O'Grady, Peter G. Linde, Peter A. McCullough, David Packham, Nosratola D. Vaziri, Keith W. Ward, David G. Warnock, Colin J. Meyer
Journal: American Journal of Nephrology
Am J Nephrol (2014) 39 (6): 499–508.
https://doi.org/10.1159/000362906
Published Online: 03 June 2014
View article titled, Mechanisms Contributing to Adverse Cardiovascular Events in Patients with Type 2 Diabetes Mellitus and Stage 4 Chronic Kidney Disease Treated with Bardoxolone Methyl
Open the PDF for Mechanisms Contributing to Adverse Cardiovascular Events in Patients with Type 2 Diabetes Mellitus and Stage 4 Chronic Kidney Disease Treated with Bardoxolone Methyl in another window